Cargando…

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2

OBJECTIVES: The interaction of COVID-19 and tuberculosis (TB) are still poor characterized. Here we evaluated the immune response specific for Micobacterium tuberculosis (Mtb) and SARS-CoV-2 using a whole-blood-based assay-platform in COVID-19 patients either with TB or latent TB infection (LTBI). M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrone, Linda, Petruccioli, Elisa, Vanini, Valentina, Cuzzi, Gilda, Gualano, Gina, Vittozzi, Pietro, Nicastri, Emanuele, Maffongelli, Gaetano, Grifoni, Alba, Sette, Alessandro, Ippolito, Giuseppe, Migliori, Giovanni Battista, Palmieri, Fabrizio, Goletti, Delia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944764/ https://www.ncbi.nlm.nih.gov/pubmed/33713816 http://dx.doi.org/10.1016/j.ijid.2021.02.090

Ejemplares similares

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
por: Petrone, Linda, et al.
Publicado: (2021)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

Humoral and cellular responses to spike of δ SARS-CoV-2 variant in vaccinated patients with immune-mediated inflammatory diseases
por: Petrone, Linda, et al.
Publicado: (2022)

VIDAS(®) TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB
por: Petruccioli, E., et al.
Publicado: (2022)

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
por: Najafi-Fard, Saeid, et al.
Publicado: (2022)

Humoral and Cellular Response to Spike of Delta SARS-CoV-2 Variant in Vaccinated Patients With Multiple Sclerosis
por: Petrone, Linda, et al.
Publicado: (2022)

Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection
por: Petruccioli, Elisa, et al.
Publicado: (2018)

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4(+) and CD8(+) T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
por: Aiello, Alessandra, et al.
Publicado: (2022)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
por: Aiello, Alessandra, et al.
Publicado: (2022)

Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach
por: D’Abramo, Alessandra, et al.
Publicado: (2021)

Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood
por: Chiacchio, Teresa, et al.
Publicado: (2011)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry
por: Alonzi, Tonino, et al.
Publicado: (2019)

Methylated HBHA Produced in M. smegmatis Discriminates between Active and Non-Active Tuberculosis Disease among RD1-Responders
por: Delogu, Giovanni, et al.
Publicado: (2011)

Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
por: Farroni, Chiara, et al.
Publicado: (2022)

Polyfunctional Specific Response to Echinococcus Granulosus Associates to the Biological Activity of the Cysts
por: Petrone, Linda, et al.
Publicado: (2015)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

IP-10 detection in urine is associated with lung diseases
por: Cannas, Angela, et al.
Publicado: (2010)

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection
por: Chiacchio, Teresa, et al.
Publicado: (2017)

ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2021)

The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
por: Petrone, Linda, et al.
Publicado: (2023)

Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages
por: La Manna, Marco Pio, et al.
Publicado: (2017)

Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination
por: Matusali, Giulia, et al.
Publicado: (2023)

Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome
por: Vita, Serena, et al.
Publicado: (2021)

Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2021)

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report
por: Gualano, Gina, et al.
Publicado: (2020)

Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies
por: Aiello, Alessandra, et al.
Publicado: (2023)

In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
por: Najafi Fard, Saeid, et al.
Publicado: (2021)

Tuberculosis Biomarkers: From Diagnosis to Protection
por: Goletti, Delia, et al.
Publicado: (2016)

Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis
por: Tempestilli, Massimo, et al.
Publicado: (2022)

Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis
por: Tempestilli, Massimo, et al.
Publicado: (2021)

Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
por: Farroni, Chiara, et al.
Publicado: (2022)

COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
por: García-García, José-María, et al.
Publicado: (2022)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
por: Cantini, Fabrizio, et al.
Publicado: (2017)

Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis
por: Musso, Maria, et al.
Publicado: (2019)

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
por: Cantini, Fabrizio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_evq46vofoo7qckodkhejj01jjr